BCM
CELL

Bridgeway Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bridgeway Capital Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-175,000
Closed -$85.8K – 1452
2023
Q2 		$85.8K Buy
175,000
+8,605
+5% +$7.04K ﹤0.01% 1280
2023
Q1 		$193K Sell
166,395
-8,805
-5% -$16.1K 0.01% 1115
2022
Q4 		$470K Buy
+175,200
New +$462K 0.01% 893

Other funds holding CELL

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bridgeway Capital Management's CELL Position: Q3 2023 in Review

Bridgeway Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 175,000 shares — an estimated $85.8K sold.

Bridgeway Capital Management first reported a position in CELL in Q4 2022 and held it in 3 quarters. The position peaked at $470K in Q4 2022. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Bridgeway Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 175,000 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $85.8K.
  • Bridgeway Capital Management first reported a position in PhenomeX Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Bridgeway Capital Management's PhenomeX Inc. Common Stock position peaked at $470K in Q4 2022.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.